Chemical Probes logo
AX15836 | AX15836 : ATP competitive inhibitor of MAPK7
RATINGS:
Cellular Use: (3 reviews)

In Model Organisms: (1 reviews)
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
MAPK7
  • Kd:8 nM
  • Kd:9 nM
ATP competitive
500 nM

Selectivity

In Vitro Selectivity Assessment

Potency: Kd - BRD4 >1 uM, kinases other than ERK5 > 1 uM

Potency Assay Off-Target:
other kinases: KiNativ (www.kinativ.com)
Selectivity Assessment Description:
BRD4: DiscoveRx (https://www.discoverx.com/targets/epigenetics/bromodomain)
In Cell Selectivity Assessment

Potency: IC50 - kinases other than ERK5 > 1 uM

Potency Assay Off-Target:
KiNativ
Selectivity Assessment Description:
AX15836 was not active in an E-selectin HUVEC assay, whereas other dual inhibitors of ERK5 and BE ...

Potency
Cellular
In Vitro

MAPK7

Mode of Action: ATP competitive

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1073/pnas.1609019113

In Vivo Validations

Mouse
Dose: 50 mg/kg
Route of delivery: Oral
Plasma half life: 2.7 hr

DOI Reference: 10.1073/pnas.1609019113

Orthogonal Probes def

BAY-885
XMD8-92

Chemical Information

Molecular Formula C32H40N8O5S
SMILEs CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(S(C)(=O)=O)c1ccccc1C(=O)N2C
InChI InChI=1S/C32H40N8O5S/c1-5-45-28-20-22(30(41)39-14-12-23(13-15-39)38-18-16-36(2)17-19-38)10-11-25(28)34-32-33-21-27-29(35-32)40(46(4,43)44)26-9-7-6-8-24(26)31(42)37(27)3/h6-11,20-21,23H,5,12-19H2,1-4H3,(H,33,34,35)
Molecular weight 648.28 Da
AlogP 3.1586000000000007
HBond acceptors 13
HBond donors 1
Atoms 86

References

Publications

Cross References

canSARChEMBLBindingDBPubMedPubMed

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews

by SERP
(on 11 Dec 2016 )
Cellular Use Rating
This probe might be suitable for in vivo studies via non-standard dosing technologies (minipump or IP injection, twice daily with CYP inhibitor co-dosing) but not enough ADME data are provided to know...
by SERP
(on 22 Mar 2017 )
Cellular Use Rating
In Model Organisms
A thorough exploration of the cellular effects of the compound is presented, but the DMPK data are not sufficiently good to allow in vivo evaluation via standard oral or IV dosing.
by SERP
(on 30 Mar 2017 )
Cellular Use Rating
The probe is a potent and selective ERK5 inhibitor. The data look convincing, and selectivity against other kinases is particularly strong (limited other selectivity data disclosed aside from key bromodomain...
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria